| 摘要 |
<p>This invention describes a stabilized steroid composition comprising from 0.01% to 0.5% by weight of the steroid 9.alpha.-fluoro-21-chloro-11.beta.,16.alpha.,17.alpha.-trihydroxypregn-4-ene-3,20-dione, 16,17acetonide, 0.005 to 0.2% by weight of an antioxidant selected from the group consisting of propyl gallate, butylated hydroxytoluene, butylated hydroxyanisole, sodium bisulfite, sodium metabisulfite, and ascorbic acid, and polyethylene glycol or a polyethylene glycol ester, said polyethylene glycol or polyethylene glycol ester having a polyethylene glycol molecular weight of from 200 to 7500 and, optionally, including an oleaginous material. This composition is useful in the treatment of various dermatoses.</p> |
